<産業資料/調査レポートの題名> 2022年7月19日

ハイドロゲルドレッシングのヨーロッパ市場2020-2024


◆英文タイトル:Hydrogel Dressing Market in Europe 2020-2024

01: EXECUTIVE SUMMARY
02: SCOPE OF THE REPORT
1. 2.1 Preface
2. 2.2 Currency conversion rates for US$
03: MARKET LANDSCAPE
3. Market ecosystem
4. Market characteristics
5. Market segmentation analysis
6. Value Chain Analysis
04: MARKET SIZING
7. Market definition
8. Market sizing 2019
9. Market size and forecast 2019-2024
05: FIVE FORCES ANALYSIS
10. Bargaining power of buyers
11. Bargaining power of suppliers
12. Threat of new entrants
13. Threat of substitutes
14. Threat of rivalry
15. Market condition
06: MARKET SEGMENTATION BY PRODUCT
16. Market segmentation by product
17. Comparison by product
18. Amorphous hydrogel dressings – Market size and forecast 2019-2024
19. Impregnated hydrogel dressings – Market size and forecast 2019-2024
20. Hydrogel sheet dressings – Market size and forecast 2019-2024
21. Market opportunity by product
07: CUSTOMER LANDSCAPE
08: GEOGRAPHIC LANDSCAPE
22. Geographic segmentation
23. Geographic comparison
24. Germany – Market size and forecast 2019-2024
25. UK – Market size and forecast 2019-2024
26. France – Market size and forecast 2019-2024
27. Rest of Europe – Market size and forecast 2019-2024
28. Key leading countries
29. Market opportunity
09: DECISION FRAMEWORK
10: DRIVERS AND CHALLENGES
30. Market drivers
31. Market challenges
11: MARKET TRENDS
32. Increasing initiatives by public organizations
33. Ongoing healthcare reforms in France
34. Advances in on-demand dissolvable hydrogel dressings
12: VENDOR LANDSCAPE
35. Overview
36. Landscape disruption
37. Competitive scenario
13: VENDOR ANALYSIS
38. Vendors covered
39. Vendor classification
40. Market positioning of vendors
41. 3M Co.
42. B. Braun Melsungen AG
43. Cardinal Health Inc.
44. Coloplast Group
45. ConvaTec Group Plc
46. Integra LifeSciences Holdings Corp.
47. Lohmann & Rauscher GmbH & Co. KG
48. McKesson Corp.
49. Medline Industries Inc.
50. Smith & Nephew Plc
14: APPENDIX
51. Research methodology
52. List of abbreviations
53. Definition of market positioning of vendors
15: EXPLORE TECHNAVIO


Exhibit 01: Global healthcare supplies market
Exhibit 02: Segments of global healthcare supplies market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Vendors: Key offerings
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Regional market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Number of people aged 65 years and above in EU countries in 2005 and 2018 (in millions)
Exhibit 10: Regional market: Year-over-year growth 2020-2024 (%)
Exhibit 11: Five forces analysis 2019
Exhibit 12: Five forces analysis 2024
Exhibit 13: Bargaining power of buyers
Exhibit 14: Bargaining power of suppliers
Exhibit 15: Threat of new entrants
Exhibit 16: Threat of substitutes
Exhibit 17: Threat of rivalry
Exhibit 18: Market condition – Five forces 2019
Exhibit 19: Product – Market share 2019-2024 (%)
Exhibit 20: Comparison by product
Exhibit 21: Amorphous hydrogel dressings – Market size and forecast 2019-2024 ($ millions)
Exhibit 22: Amorphous hydrogel dressings – Year-over-year growth 2020-2024 (%)
Exhibit 23: Impregnated hydrogel dressings – Market size and forecast 2019-2024 ($ millions)
Exhibit 24: Impregnated hydrogel dressings – Year-over-year growth 2020-2024 (%)
Exhibit 25: Hydrogel sheet dressings – Market size and forecast 2019-2024 ($ millions)
Exhibit 26: Hydrogel sheet dressings – Year-over-year growth 2020-2024 (%)
Exhibit 27: Market opportunity by product
Exhibit 28: Customer landscape
Exhibit 29: Market share by geography 2019-2024 (%)
Exhibit 30: Geographic comparison
Exhibit 31: Germany – Market size and forecast 2019-2024 ($ millions)
Exhibit 32: Germany – Year-over-year growth 2020-2024 (%)
Exhibit 33: UK – Market size and forecast 2019-2024 ($ millions)
Exhibit 34: UK – Year-over-year growth 2020-2024 (%)
Exhibit 35: France – Market size and forecast 2019-2024 ($ millions)
Exhibit 36: France – Year-over-year growth 2020-2024 (%)
Exhibit 37: Rest of Europe – Market size and forecast 2019-2024 ($ millions)
Exhibit 38: Rest of Europe – Year-over-year growth 2020-2024 (%)
Exhibit 39: Key leading countries
Exhibit 40: Market opportunity
Exhibit 41: Transmission of infections
Exhibit 42: Impact of drivers and challenges
Exhibit 43: Vendor landscape
Exhibit 44: Landscape disruption
Exhibit 45: Vendors covered
Exhibit 46: Vendor classification
Exhibit 47: Market positioning of vendors
Exhibit 48: 3M Co. – Vendor overview
Exhibit 49: 3M Co. – Business segments
Exhibit 50: 3M Co. – Organizational developments
Exhibit 51: 3M Co. – Geographic focus
Exhibit 52: 3M Co. – Segment focus
Exhibit 53: 3M Co. – Key offerings
Exhibit 54: B. Braun Melsungen AG – Vendor overview
Exhibit 55: B. Braun Melsungen AG – Business segments
Exhibit 56: B. Braun Melsungen AG – Organizational developments
Exhibit 57: B. Braun Melsungen AG – Geographic focus
Exhibit 58: B. Braun Melsungen AG – Segment focus
Exhibit 59: B. Braun Melsungen AG – Key offerings
Exhibit 60: Cardinal Health Inc. – Vendor overview
Exhibit 61: Cardinal Health Inc. – Business segments
Exhibit 62: Cardinal Health Inc. – Organizational developments
Exhibit 63: Cardinal Health Inc. – Geographic focus
Exhibit 64: Cardinal Health Inc. – Segment focus
Exhibit 65: Cardinal Health Inc. – Key offerings
Exhibit 66: Coloplast Group – Vendor overview
Exhibit 67: Coloplast Group – Product segments
Exhibit 68: Coloplast Group – Organizational developments
Exhibit 69: Coloplast Group – Geographic focus
Exhibit 70: Coloplast Group – Segment focus
Exhibit 71: Coloplast Group – Key offerings
Exhibit 72: ConvaTec Group Plc – Vendor overview
Exhibit 73: ConvaTec Group Plc – Business segments
Exhibit 74: ConvaTec Group Plc – Organizational developments
Exhibit 75: ConvaTec Group Plc – Geographic focus
Exhibit 76: ConvaTec Group Plc – Segment focus
Exhibit 77: ConvaTec Group Plc – Key offerings
Exhibit 78: Integra LifeSciences Holdings Corp. – Vendor overview
Exhibit 79: Integra LifeSciences Holdings Corp. – Business segments
Exhibit 80: Integra LifeSciences Holdings Corp. – Organizational developments
Exhibit 81: Integra LifeSciences Holdings Corp. – Geographic focus
Exhibit 82: Integra LifeSciences Holdings Corp. – Segment focus
Exhibit 83: Integra LifeSciences Holdings Corp. – Key offerings
Exhibit 84: Lohmann & Rauscher GmbH & Co. KG – Vendor overview
Exhibit 85: Lohmann & Rauscher GmbH & Co. KG – Product segments
Exhibit 86: Lohmann & Rauscher GmbH & Co. KG – Organizational developments
Exhibit 87: Lohmann & Rauscher GmbH & Co. KG – Key offerings
Exhibit 88: McKesson Corp. – Vendor overview
Exhibit 89: McKesson Corp. – Business segments
Exhibit 90: McKesson Corp. – Organizational developments
Exhibit 91: McKesson Corp. – Geographic focus
Exhibit 92: McKesson Corp. – Segment focus
Exhibit 93: McKesson Corp. – Key offerings
Exhibit 94: Medline Industries Inc. – Vendor overview
Exhibit 95: Medline Industries Inc. – Product segments
Exhibit 96: Medline Industries Inc. – Organizational developments
Exhibit 97: Medline Industries Inc. – Key offerings
Exhibit 98: Smith & Nephew Plc – Vendor overview
Exhibit 99: Smith & Nephew Plc – Product segments
Exhibit 100: Smith & Nephew Plc – Organizational developments
Exhibit 101: Smith & Nephew Plc – Geographic focus
Exhibit 102: Smith & Nephew Plc – Segment focus
Exhibit 103: Smith & Nephew Plc – Key offerings
Exhibit 104: Validation techniques employed for market sizing
Exhibit 105: Definition of market positioning of vendors


LINEで送る
Share on LinkedIn
このエントリーをはてなブックマークに追加
Bookmark this on BuzzURL
Bookmark this on Yahoo Bookmark